Indications and uses
Apply on Skin only ; for temporary relief of minor aches & pains of muscles & joints associated with sports and/or aging symptoms: ■ Simple backache ■ arthritis ■ strains ■ bruises ■ sprains
Apply on Skin only ; for temporary relief of minor aches & pains of muscles & joints associated with sports and/or aging symptoms: ■ Simple backache ■ arthritis ■ strains ■ bruises ■ sprains
If prone to allergic reaction from aspirin or salicylates, consult a doctor before use Adults and children12 years of age and over : ■ clean and dry affected area. ■ apply to affected area not more than 2 times a day. Children under 12 years of age : ■ consult a doctor
Capsaicin natural extract 0.25 % as capsaicin
Camphor 3 %
Menthol 12 %
Methyl Salicylate 15 %
Eucalyptus Oil 15 %
Capsaicin natural extract ........................................... .Topical Analgesic
Camphor …………………………………………….........Topical Analgesic
Menthol ....................................................................... Topical Analgesic
Methyl Salicylate ..........................................................Topical Analgesic
Eucalyptus Oil ..............................................................Topical Analgesic
Apply on Skin only; for temporary relief of minor aches & pains of muscles & joints associated with sports and/or aging symptoms:
■ Simple backache ■ arthritis ■ strains ■ bruises ■ sprains
Keep out reach of children
If swallowed, get medical help or contact poison control center immediately.
Do not use
■ on wounds or damaged skin.
■ with a heating pad
■ with, or at the same time as, other external analgesic products.
■ if you are allergic to any ingredients of this product.
When using this product:
■ do not use otherwise than as directed.
■ avoid contact with eyes, mucous membranes or rashes.
Stop use and consult a doctor for:
■ rash, itching or excessive skin irritation develops.
■ conditions worsen.
■ symptoms persist for more than7 days.
■ symptoms clear up and occur again within a few days.
If swallowed, get medical help or contact poison control center immediately.
If prone to allergic reaction from aspirin or salicylates, consult a doctor before use
Adults and children12 years of age and over:
■ clean and dry affected area.
■ apply to affected area not more than 2 times a day.
Children under 12 years of age:
■ consult a doctor
If you are pregnant or breastfeeding, consult with your physician or a healthcare provider before use.
Warnings
If swallowed, get medical help or contact poison control center immediately.
■ consult a doctor
Purified water, Ethanol, Cetyl alcohol, Polysorbate 80, Sorbitan monolaurate, Isopropyl myristate.
■ Due to its unique formulation, the solution can turn into different levels of white translucent, milky cloudiness at warmer temperatures; This is totally normal. Upon returning to cooler temperatures it should regain its typical transparency state.
■ Avoid storing product in direct sunlight.
■ Protect product from excessive moisture.
NDC#61079-025-13
bB Medicated Oil Pain Reliever
Extra Strength
0.5 FL. OZ. (13 mL)
bB BioChem Laboratories, Inc.
Distributed by
bB BioChem Laboratories, Inc.
Santa Ana, CA 92705
bB BioChemUSA.com
Adults and children12 years of age and over:
Children under 12 years of age:
NDC#61079-014-13
bB Medicated Oil Pain Reliever
Sensitive Strength-Capsaicin 0.14/100
0.5 FL. OZ. (13 mL)
bB BioChem Laboratories, Inc.
Distributed by
bB BioChemLaboratories, Inc.
Santa Ana, CA 92705
bBBioChemUSA.com
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1598277 | camphor 3 % / capsaicin 0.25 % / eucalyptus oil 15 % / menthol 12 % / methyl salicylate 15 % Topical Oil | PSN | 8 |
| 1598277 | camphor 30 MG/ML / capsaicin 2.5 MG/ML / Eucalyptus oil 150 MG/ML / menthol 120 MG/ML / methyl salicylate 150 MG/ML Topical Oil | SCD | 8 |
| 1598277 | camphor 3 % / capsaicin 0.25 % / eucalyptus oil 15 % / menthol 12 % / methyl salicylate 15 % Topical Oil | SY | 8 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 473d070d-1c38-488e-b991-c4d1bf45aab8 | Product name | 1 | 20210201 |
| dea2eded-d1e7-46bb-9a3d-f8dc20de6277 | Product name | 1 | 20190408 |
| 7792dadb-52b6-46b6-8fdf-80b1171065b5 | Product name | 1 | 20180810 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 61079-014-13 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-3a57-f424-e053-dadaa90a57ce | bB MEDICATED PAIN RELIEVING OIL APPLY ON SKIN ONLY |
| 61079-025-13 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-3a57-f424-e053-dadaa90a57ce | bB MEDICATED PAIN RELIEVING OIL APPLY ON SKIN ONLY |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61079-014-13 | bB Medicated Pain Relieving Oil | 13 g in 1 BOTTLE, GLASS | OIL | 13 | 8 | |
| 61079-025-13 | bB Medicated Pain Relieving Oil | 13 g in 1 BOTTLE, GLASS | OIL | 13 | 8 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 61079-014 | BB MEDICATED PAIN RELIEVING OIL OIL [BB BIOCHEM LABORATORIES, INC.] | 8 | Legacy NDC, 1 package rows | 20150105_07b43c31-a4d2-5c29-e054-00144ff88e88.zip |
| 61079-025 | BB MEDICATED PAIN RELIEVING OIL OIL [BB BIOCHEM LABORATORIES, INC.] | 8 | Legacy NDC, 1 package rows | 20150105_07b43c31-a4d2-5c29-e054-00144ff88e88.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CAMPHOR (NATURAL) | ACTIVE INGREDIENT | N20HL7Q941 | 8 | |
| CAMPHOR (SYNTHETIC) | ACTIVE INGREDIENT | 5TJD82A1ET | 8 | |
| CAPSAICIN | ACTIVE INGREDIENT | S07O44R1ZM | 8 | |
| EUCALYPTUS OIL | ACTIVE INGREDIENT | 2R04ONI662 | 8 | |
| LEVOMENTHOL | ACTIVE INGREDIENT | BZ1R15MTK7 | 8 | |
| METHYL SALICYLATE | ACTIVE INGREDIENT | LAV5U5022Y | 8 | |
| CAMPHOR (NATURAL) | ACTIVE MOIETY | N20HL7Q941 | 8 | |
| CAMPHOR (SYNTHETIC) | ACTIVE MOIETY | 5TJD82A1ET | 8 | |
| CAPSAICIN | ACTIVE MOIETY | S07O44R1ZM | 8 | |
| EUCALYPTUS OIL | ACTIVE MOIETY | 2R04ONI662 | 8 | |
| LEVOMENTHOL | ACTIVE MOIETY | BZ1R15MTK7 | 8 | |
| SALICYLIC ACID | ACTIVE MOIETY | O414PZ4LPZ | 8 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 8 | |
| CETYL ALCOHOL | INACTIVE INGREDIENT | 936JST6JCN | 8 | |
| ISOPROPYL MYRISTATE | INACTIVE INGREDIENT | 0RE8K4LNJS | 8 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | 8 | |
| SORBITAN MONOLAURATE | INACTIVE INGREDIENT | 6W9PS8B71J | 8 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 8 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 61079-025 | 61079-025-13 |
| 61079-014 | 61079-014-13 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CETYL ALCOHOL | 936JST6JCN | IACT |
| POLYSORBATE 80 | 6OZP39ZG8H | IACT |
| SORBITAN MONOLAURATE | 6W9PS8B71J | IACT |
| ISOPROPYL MYRISTATE | 0RE8K4LNJS | IACT |
| ALCOHOL | 3K9958V90M | IACT |
| WATER | 059QF0KO0R | IACT |
| CAMPHOR (SYNTHETIC) | 5TJD82A1ET | ACTIB |
| LEVOMENTHOL | BZ1R15MTK7 | ACTIB |
| METHYL SALICYLATE | LAV5U5022Y | ACTIB |
| EUCALYPTUS OIL | 2R04ONI662 | ACTIB |
| CAPSAICIN | S07O44R1ZM | ACTIB |
| CETYL ALCOHOL | 936JST6JCN | IACT |
| POLYSORBATE 80 | 6OZP39ZG8H | IACT |
| SORBITAN MONOLAURATE | 6W9PS8B71J | IACT |
| ISOPROPYL MYRISTATE | 0RE8K4LNJS | IACT |
| ALCOHOL | 3K9958V90M | IACT |
| WATER | 059QF0KO0R | IACT |
| EUCALYPTUS OIL | 2R04ONI662 | ACTIB |
| CAPSAICIN | S07O44R1ZM | ACTIB |
| CAMPHOR (NATURAL) | N20HL7Q941 | ACTIB |
| METHYL SALICYLATE | LAV5U5022Y | ACTIB |
| LEVOMENTHOL | BZ1R15MTK7 | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | SOLUTION / INTRAVENOUS | 900 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | SUSPENSION / OPHTHALMIC | 0.5 %w/v | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | SUPPOSITORY / RECTAL | 72.15 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| SORBITAN MONOLAURATE | SORBITAN MONOLAURATE | 6W9PS8B71J | AEROSOL, FOAM / TOPICAL | 341 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, SUSPENSION / INTRAMUSCULAR | 4 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | TABLET, FILM COATED / ORAL | NA | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | CAPSULE, COATED / ORAL | 0.04 mg | ||
| SORBITAN MONOLAURATE | SORBITAN MONOLAURATE | 6W9PS8B71J | SUSPENSION / ORAL | 2.5 mg/5ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | SYSTEM / TRANSDERMAL | 113 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, POWDER, FOR SUSPENSION / INTRA-ARTICULAR | 5 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | SPRAY, METERED / NASAL | 0.1 mg/1ml | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | AEROSOL, FOAM / RECTAL | 17 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | CAPSULE, DELAYED RELEASE / ORAL | 59 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | SUPPOSITORY / VAGINAL | 28 mg | ||
| SORBITAN MONOLAURATE | SORBITAN MONOLAURATE | 6W9PS8B71J | CREAM / TOPICAL | 0.5 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | DROPS / OPHTHALMIC | 0.05 %w/w | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | POWDER / ORAL | 66 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | SOLUTION / ORAL | 907 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, SOLUTION / INTRAVENOUS | 1170 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 34 mg | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | AEROSOL / TOPICAL | 9.3 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, SUSPENSION / SOFT TISSUE | 4 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | SOLUTION / AURICULAR (OTIC) | 0.2 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | CAPSULE / ORAL | 418.37 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | OIL / TOPICAL | 213 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 8 mg | ||
| SORBITAN MONOLAURATE | SORBITAN MONOLAURATE | 6W9PS8B71J | SPRAY, METERED / NASAL | 1 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | CAPSULE, COATED PELLETS / ORAL | 2 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | CONCENTRATE / INTRAVENOUS | 4680 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | AEROSOL, FOAM / VAGINAL | 3 %w/w | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | ELIXIR / ORAL | 2.5 mg/15ml | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | CAPSULE, EXTENDED RELEASE / ORAL | 10 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | EMULSION / TOPICAL | 34050 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | EMULSION / TOPICAL | NA | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | SOLUTION, GEL FORMING, EXTENDED RELEASE / OPHTHALMIC | 0.05 %w/w | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | SUSPENSION/ DROPS / OPHTHALMIC | 1 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, SUSPENSION / SUBCUTANEOUS | 0.3 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | 1 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | TABLET / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | SUSPENSION / TOPICAL | 2.01 %w/w | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | SUSPENSION / RESPIRATORY (INHALATION) | 1 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | GEL / TOPICAL | 12 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 0bc4e3b7-24a6-435a-e054-00144ff88e88 | 07b43c31-a4d2-5c29-e054-00144ff88e88 | 2014-11-01 | Warnings | 0bc4e3b7-24a6-435a-e054-00144ff88e88 07b43c31-a4d2-5c29-e054-00144ff88e88 |
Adverse event summaries are temporarily unavailable. Other product information remains available.